Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Biochem Pharmacol ; 224: 116230, 2024 06.
Artigo em Inglês | MEDLINE | ID: mdl-38643905

RESUMO

One of the effective therapeutic strategies to treat rheumatoid arthritis (RA)-related bone resorption is to target excessive activation of osteoclasts. We discovered that 6-O-angeloylplenolin (6-OAP), a pseudoguaianolide from Euphorbia thymifolia Linn widely used for the treatment of RA in traditional Chinese medicine, could inhibit RANKL-induced osteoclastogenesis and bone resorption in both RAW264.7 cells and BMMs from 1 µM and protect a collagen-induced arthritis (CIA) mouse model from bone destruction in vivo. The severity of arthritis and bone erosion observed in paw joints and the femurs of the CIA model were attenuated by 6-OAP administered at both dosages (1 or 5 mg/kg, i.g.). BMD, Tb.N and BV/TV were also improved by 6-OAP treatment. Histological analysis and TRAP staining of femurs further confirmed the protective effects of 6-OAP on bone erosion, which is mainly due to reduced osteoclasts. Molecular docking indicated that c-Src might be a target of 6-OAP and phosphorylation of c-Src was suppressed by 6-OAP treatment. CETSA and SPR assay further confirmed the potential interaction between 6-OAP and c-Src. Three signaling molecules downstream of c-Src that are vital to the differentiation and function of osteoclasts, NF-κB, c-Fos and NFATc1, were also suppressed by 6-OAP in vitro. In summary, the results demonstrated that the function of c-Src was disrupted by 6-OAP, which led to the suppression of downstream signaling vital to osteoclast differentiation and function. In conclusion, 6-OAP has the potential to be further developed for the treatment of RA-related bone erosion.


Assuntos
Artrite Experimental , Reabsorção Óssea , NF-kappa B , Fatores de Transcrição NFATC , Osteoclastos , Osteogênese , Animais , Camundongos , Fatores de Transcrição NFATC/metabolismo , Células RAW 264.7 , Reabsorção Óssea/tratamento farmacológico , Reabsorção Óssea/metabolismo , Reabsorção Óssea/prevenção & controle , Artrite Experimental/tratamento farmacológico , Artrite Experimental/patologia , Artrite Experimental/metabolismo , Artrite Experimental/induzido quimicamente , Osteogênese/efeitos dos fármacos , NF-kappa B/metabolismo , Osteoclastos/efeitos dos fármacos , Osteoclastos/metabolismo , Masculino , Transdução de Sinais/efeitos dos fármacos , Proteína Tirosina Quinase CSK/metabolismo , Simulação de Acoplamento Molecular , Quinases da Família src/metabolismo , Quinases da Família src/antagonistas & inibidores
2.
Guang Pu Xue Yu Guang Pu Fen Xi ; 30(4): 883-6, 2010 Apr.
Artigo em Chinês | MEDLINE | ID: mdl-20545123

RESUMO

The rise and decay curves of Er3+ 4F9/2 upconversion emission in oxyfluoride tellurite glass were measured under the excitation at 808 nm from a laser diode driven by square waves. The lifetime of the intermediate state could be determined via rise times. Then the accumulation process of the 4F9/2 population was confirmed. The excitation mechanism of up-conversion red emission under 808 nm excitation was confirmed by the rate equations and analyzing the relationship between the time constants of the rise and decay processes and the intermediate state. Square wave excited upconversion emission may also be used for measuring lifetimes of infrared energy levels with a conventional photomultiplier tube.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA